Global Cardiac POC Testing Devices Market to Reach US$1.7 Billion by the Year 2026

DUBLIN, Aug. 16, 2022 /PRNewswire/ -- The "Cardiac POC Testing Devices - Global Market Trajectory & Analytics" report has been added to ResearchAndMarkets.com's offering.

Global Cardiac POC Testing Devices Market to Reach US$1.7 Billion by the Year 2026

Cardiac POC testing devices help in assessing cholesterol and blood glucose levels. Cardiac POC assay test kits deliver accurate results promptly and cost-effectively with standardization for minimizing operational errors. Cardiac POC diagnostic kits are finding increasing application in emerging countries with remote geographical areas, dearth of skilled medical personnel and testing laboratory infrastructure.

The increasing adoption of sensitivity and premium-priced POC Troponin tests is contributing to the growth of the global market. The growing move towards value-based and efficient healthcare service delivery against the backdrop of stringent budgets is boosting the prospects for POC Cardiac testing market. Moreover, the majority of medical professionals opt of POC cardiac testing to quickly monitor the condition of patients experiencing chest pain or other heart ailment symptoms in emergency care environments. The global phenomenon of the burgeoning aging populace is driving demand for POC test kits for use in home healthcare and old age homes.

Growing patient awareness and the increasing availability of over the counter POC tests is a major factor propelling the POC tests market. At a time when the global healthcare industry is transitioning from disease treatment to disease prevention through increased involvement with patients, POC diagnostic kits are playing an instrumental role in reducing the risk of occurrence and the intensity of prevailing diseases by facilitating prompt diagnosis and earlier clinical intervention.

Amid the COVID-19 crisis, the global market for Cardiac POC Testing Devices estimated at US$1.4 Billion in the year 2022, is projected to reach a revised size of US$1.7 Billion by 2026, growing at a CAGR of 5.8% over the analysis period.

The U.S. Market is Estimated at $531.3 Million in 2022, While China is Forecast to Reach $192.6 Million by 2026

The Cardiac POC Testing Devices market in the U.S. is estimated at US$531.3 Million in the year 2022. The country currently accounts for a 37.36% share in the global market. China, the world's second largest economy, is forecast to reach an estimated market size of US$192.6 Million in the year 2026 trailing a CAGR of 7.4% through the analysis period. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 4.6% and 5.9% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 4.8% CAGR while Rest of European market (as defined in the study) will reach US$204.7 Million by the end of the analysis period. The United States represents the largest market, driven by high prevalence of cardiovascular diseases, higher levels of physician and patient awareness, favorable government policies, and high usage of cardiac tests. The Asia Pacific region is also growing steadily on account of the increasing awareness about cardiac diagnosis and treatment as well as rising healthcare expenditure.

Key Topics Covered:

I. METHODOLOGY

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW

2. FOCUS ON SELECT PLAYERS

3. MARKET TRENDS & DRIVERS

• Rising Incidence, Mounting Economic and Social Burden of Cardiovascular Disease to Drive Market Growth
• Leading Causes of Mortality Worldwide: Number of Deaths in Millions & % Share of Deaths by Cause for 2017
• Leading Causes of Mortality for Low-Income and High-Income Countries
• Aging Global Population at High Risk of Cardiac Illnesses Present Favorable Outlook for Cardiac POC Testing Devices
• Expanding Elderly Population Worldwide: Breakdown of Number of People Aged 65+ Years in Million by Geographic Region for the Years 2019 and 2030
• Technological Advances to Drive the Cardiac POC Diagnostics Market
• An Overview of Available Quantitative and Qualitative POC Devices for Measuring Multiple Cardiac Markers
• Increasing Demand for Troponin Tests Drive the Cardiac POC Market
• Evolution of the Troponin Assay
• Implementation of Unique & new Troponin-Based Tests Helps in Diagnosing MI
• Optimizing Novel Troponin Assay Benefits
• Troponin Applications: A Promising Future
• Brain Natriuretic Peptide (BNP) Test Registers Significant Growth
• Myoglobin Test
• Myoglobin Test
• Cardiac Biomarker Play Critical Role in Stroke Diagnosis

4. GLOBAL MARKET PERSPECTIVE

III. MARKET ANALYSIS

IV. COMPETITION

 Companies Mentioned

• Abbott Laboratories
• ACON Laboratories, Inc.
• Alfa Scientific Designs, Inc.
• American Screening Corporation, Inc.
• BD Medical device company
• Beckman Coulter Inc.
• Biomerica, Inc.
• Bio-Rad Laboratories, Inc.
• Danaher Corporation
• F. Hoffmann-La Roche AG
• LifeSign LLC
• Medtronic plc
• Nano-Ditech Corporation
• Nexus Dx, Inc.
• Nova Biomedical Corporation
• PTS Diagnostics
• Sekisui Medical Co., Ltd.
• Siemens Healthineers AG
• Werfen Life Group

For more information about this report visit https://www.researchandmarkets.com/r/p9rxmh

Media Contact:
Research and Markets
Laura Wood, Senior Manager
[email protected]
 
For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
 
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

Logo: https://mma.prnewswire.com/media/539438/Research_and_Markets_Logo.jpg

SOURCE Research and Markets